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Dr Yoshidadoi:10.1016/j.jtcvs.2004.07.038Objective: This study was undertaken to determine the recurrence rate after limited
resection of small lung carcinoma and to evaluate intraoperative frozen-section
examination accuracy for Noguchi classification.
Methods: Enrollment requirements were as follows: pulmonary nodule 2 cm or
smaller, diagnosed or suspected clinical T1 N0 M0 carcinoma in the lung periphery,
and ground-glass opacity findings and lack of evident pleural indentations or
vascular convergence on high-resolution computed tomographic scan. A wedge or
segmental resection specimen, removed with custom stapler cartridges, was imme-
diately reinflated and examined by frozen-section with hematoxylin-eosin and
Victoria blue–van Gieson stains. If the tumor was confirmed as Noguchi type A or
B with resection margins greater than 1 cm, the patient was closed and followed up
on an outpatient basis. End points were 5-year disease-free survival and intraoper-
ative classification accuracy.
Results: From August 1998 through October 2002, a total of 50 patients were
enrolled (20 men and 30 women, ages 30-77 years). Tumor sizes ranged from 2 to
21 mm (11 mm average). There were 2 Noguchi type A tumors, 23 Noguchi type
B tumors, 15 Noguchi type C tumors, 5 atypical adenomatous hyperplasias, 4
fibroses, and 1 granuloma. Frozen-section accuracy was approximately 98% (39/
40). One intraoperative type B diagnosis was revised to type C after postoperative
pathologic study. No morbidity, mortality, or recurrence has been seen with a
median follow-up of 50 months.
Conclusion: Noguchi type A and B tumors may well be in situ carcinomas, and
frozen-section examination was highly accurate. Neither local recurrence nor distant
metastases have been found to date. Limited resection initial results appear prom-
ising.
T he Lung Cancer Study Group has performed the only prospective, random-ized trial of limited resection versus lobectomy to date. They concluded thatlobectomy was the appropriate surgical treatment for T1 N0 M0 non–small
cell lung carcinomas, because limited resection resulted in greater local recurrence.1
The Lung Cancer Study Group trial did not include many small cancers, and
ground-glass opacity (GGO)2 nodules were not recognized at the time of the study.
Since then, several researchers have reported, although in retrospective study
designs, that limited resection could be an acceptable alternative for patients with T1
N0 M0 disease.3,4 We decided to do more investigations and evaluations. In 1998,
we reviewed peripheral lung cancers smaller than 1 cm in diameter and found that
almost half of them displayed an invasive nature. We concluded that tumor size
alone cannot be a positive indicator for limited resection.5
Shimosato and colleagues6 retrospectively evaluated cancer fibrotic focus or
scarring and patient prognosis. They found that increasing fibrotic focus or scarring
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tastasis, and blood vessel invasion. Patient prognosis was
poorer with increased focus or scarring. They believed that
scarring and resulting pleural indentations occurred with
tumor development.
Noguchi and associates7 developed a six-category clas-
sification for lung adenocarcinomas less than 2 cm in diam-
eter. They concluded, on the basis of histologic character-
istics and outcomes, that localized bronchioloalveolar
carcinoma (type A) and localized bronchioloalveolar carci-
noma with foci of collapse (type B) were pathologically and
biologically in situ noninvasive peripheral carcinomas,
whereas localized bronchioloalveolar carcinoma with foci
of fibroblastic proliferation (type C) was an advanced inva-
sive stage of types A and B. This differentiation required
careful histologic examination.
We speculated that if Noguchi type A and B tumors truly
are in situ, noninvasive carcinomas, limited resection might
be the procedure of choice. With this goal in mind, we
developed some unique tools and methods for intraoperative
diagnosis of these tumor types. With these methods, we
found that we were able to reliably differentiate Noguchi
types A and B from type C during the surgical procedure.
As a result, in 1998 at our institution we started a prospec-
tive limited resection clinical trial to confirm the reliability
Figure 1. Treatment sequence. PLC, Primary lung cancer
Figure 2. Customized stapler (ENDO-GIA 30 3.5/3-1; Tyco Health-
care Japan, Tokyo, Japan).
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the survival of those with limited resection based on the
tumor differentiation results for probable in situ adenocar-
cinoma in the lung periphery. We describe the study design,
unique tools and methods, and preliminary results after
completion of the planned 50 patient enrollment.
Patients and Methods
Our objectives were to evaluate intraoperative frozen-section ex-
amination in the identification of Noguchi type A or B tumors, to
perform limited resection for Noguchi A and B and other benign or
noninvasive nodules, and to determine the extent of local recur-
rence or distant metastases in all patients at 5-year follow-up.
Enrollment required patients with a tumor less than 2 cm in
diameter diagnosed or suspected as a clinical T1 N0 M0 carcinoma
in the lung periphery on the basis of a computed tomographic (CT)
scan. They had to have a high-resolution CT scan with findings
suggestive of a Noguchi type A or B tumor: GGO and lack of
evident pleural indentations or vascular convergencWritten
informed consent was obtained from each participant. Patients
with a malignancy history within the past 5 years and those not
candidates for lobectomy and systematic lymph node dissection
were excluded.
Figure 1 shows the treatment flow chart. We performed wedge
or segmental resection, depending on the tumor location. When a
tumor was deep in the middle of a segment, segmentectomy was
chosen. Also, when a tumor could not be localized during surgery,
we performed a segmentectomy to avoid missing the tumor. Our
pathologist (T.Y.) examined the frozen-section specimen immedi-
ately. If the tumor was confirmed as Noguchi type A or B with a
resection margin greater than 1 cm, the patient was closed up and
followed up on an outpatient basis. If the margin was not suffi-
cient, additional margin was resected. If the tumor was a primary
malignancy, but not type A or B, lobectomy and systematic lymph
node dissection were performed. Patients are followed up on an
outpatient basis at least every 6 months by physical check-up, plain
chest radiograph, and laboratory tests. Patients who underwent
limited resection for Noguchi type A or B disease have chest CTs
every year.
It is fairly difficult to perform Noguchi classification from a
simple frozen section. To facilitate the examination, we used
several innovative tools and techniques in our trial. We believe
these contributed significantly to the trial results. Figure 2 shows
the stapler cartridge (ENDO-GIA 30 3.5/3-1; Tyco Healthcare
Japan, Tokyo, Japan), custom modified as requested by our chief
thoracic surgeon (K.N.). Rather than three lines of staples on both
sides, it has a single staple line on the black, resected specimen
side. This makes it easier to cut a narrow pathologic examination
specimen margin strip for negative cut-end confirmation.
With no obvious specimen bronchus or bronchiole for phos-
phate-buffered saline solution injection, specimen inflation to fa-
cilitate alveolar structure observation is difficult. To inflate the
resected specimen’s alveolar structure, our pathologist used a
technique known, but not normally used in neoplastic lung disease
diagnosis.9 With the specimen in a closed, phosphate-buffered
saline solution–filled syringe, the piston was pulled back quickly
and repeatedly, reinflating the alveolar structure by replacing al-
veolar air with phosphate-buffered saline solution (Figure 3). After
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tion, the pathologist stereoscopically examined the slices, looking
for the most severe structure destruction indications. The maxi-
mum stromal destruction slices or the largest area slice were cut by
cryostat, stained with hematoxylin-eosin, and examined
microscopically.
In addition to routine hematoxylin-eosin staining, our patholo-
gist (T.Y.) thought Victoria blue–van Gieson (VvG) staining
would improve Noguchi classification accuracy, because it reveals
whether the alveolar wall elastic fibers are intact,10 providing a
powerful aid in improving intraoperative classification accuracy. If
the elastic fibers were destroyed by tumor cells, as shown in Figure
4, A, the tumor was diagnosed as Noguchi type C, whereas if they
were intact, as in Figure 4, B, the classification was type A or B.
This diagnostic judgment was based on our group’s previous
report (Yokose and associates11) that patients without stromal
destruction, as shown by VvG staining, survived 5 years without
recurrence.
Noguchi and associates7 reported no cancer recurrences at 5
years after lobectomy and lymph node dissection in the type A and
B population.7 Statistically, it is impossible to compare the limited
resection outcome for these tumors with the event-free standard
surgery outcome. We reported an 85% 5-year survival rate among
patients with tumors 2 cm or smaller and T1 N0 M0 pathologic
class who underwent lobectomy and systematic lymph node dis-
section at our institution.12 Allowing 4 local recurrences in 50
patients, a 90% confidence interval of 86% to 98% results, and the
lower limit would be better than our earlier study. We therefore
decided to recruit 50 patients, with a trial-quitting rule of 5 local
recurrence cases.
The first end point was accurate frozen-section examination
Figure 3. Specimen vacuum reinflation.results for carcinoma invasiveness. The second, and more impor-
The Journal of Thoracitant, end point was 5-year disease-free survival. This study proto-
col was reviewed by the National Cancer Center Hospital East
institutional review board and was approved in July 1998.
Results
This prospective study (August 1998–October 2002) en-
rolled 50 patients comprising only 5.3% of all patients with
resected lung cancer at our institution during this period.
There were 20 men and 30 women, with ages ranging from
30 to 77 years (average 61 years). Tumor sizes ranged from
2 to 21 mm (average 11 mm). Thirty patients had wedge
resection, 6 segmentectomy, and 14 lobectomy with lymph
node dissection. Nineteen of the 30 wedge procedures were
performed thoracoscopically by three-port access, and the
other 11 needed a small thoracotomy.
Three-port procedures were performed when the tumor
Figure 4. VvG staining showing elastic fiber destruction in type C
tumor (A) and intact elastic fibers in type A tumor (B). (Magnifi-
cation 100.)was subpleural or when the tumor was shallow or hard
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the ports. Initially, because of the nature of GGOs, we were
not sure that we would be able to palpate and localize these
lesions. However, we found the GGO-containing lung pa-
renchyma to have a different texture than the surrounding
normal parenchyma. When it was impossible to determine
the tumor location or periphery through the thoracoscopy
ports, the procedure was converted to a small thoracotomy.
Segmentectomy and lobectomy were done through a muscle-
sparing thoracotomy, typically about 12 cm in length.
During the trial, Noguchi classification assessment took
about an hour because of the extensive image recording
required for study purposes. There were 2 Noguchi type A
tumors, 23 Noguchi type B tumors, 15 Noguchi type C
tumors, 5 atypical adenomatous hyperplasias (AAH), 4 fi-
broses and 1 granuloma. Their size distribution is summa-
rized in Table 1. In addition to the intraoperative slides,
further postoperative slides were prepared and studied. The
postoperative slides did not differ significantly from the
intraoperative slides. One initial frozen-section type B di-
agnosis was revised to type C after postoperative pathologic
study. We discussed this with the patient in detail, and he
chose not to have any further treatment. He is still alive
without any signs of recurrence after more than 5 years.
No morbidity or mortality has been seen. During the
follow-up period, with a range of 19 to 68 months (median
50 months), as this is being written (May 2004), there have
been no recurrences. Enrollment concluded without a forced
quit.
Discussion
The Lung Cancer Study Group conducted a prospective
randomized trial to evaluate the role of limited resection
versus lobectomy for T1 N0 M0 non–small cell lung
carcinomas. They reported significantly increased local
recurrence and marginally but not significantly higher
cancer death rates in the limited resection group relative
TABLE 1. Histologic subtype and tumor size distribution in
resected specimens
Subtype
No. of
cases
Range
(mm)
Median
(mm)
Resection
type
(W/S/L)
Type A 2 9-10 — 1/1/0
Type B 23 6-21 12 21/2/0
Type C 15 10-19 14 1/0/14
Atypical adenomatous
hyperplasia
5 5-14 8 2/3/0
Fibrosis 4 6-15 10 4/0/0
Granuloma 1 6 — 1/0/0
W/S/L, Wedge resection/segmentectomy/lobectomy plus lymph node dis-
section, in numbers of patients.to the lobectomy group. On the basis of their observa-
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treatment of choice for patients with T1 N0 M0 non–
small cell lung carcinomas.1 However, there has been
some question whether limited resection is always con-
traindicated. We reported a retrospective review of pe-
ripheral lung cancers of all types less than 1 cm in
diameter in 1998.5 Of the 16 small tumors, 7 displayed an
invasive nature. We therefore concluded that tumor size
alone is not a sufficient indicator for limited resection.
This observation is consistent with a recent report on
subcentimeter lung cancers from the Mayo Clinic.13
However, in patients with impaired respiratory function,
limited resection has been tried and has often yielded
acceptable outcomes.14 Several researchers have re-
ported, although in retrospective studies, that limited
resection could be an acceptable alternative in patients
with T1 N0 M0 disease and insufficient pulmonary
reserve.3,4
Noguchi and associates7 conjectured that type A and type
B tumors are in situ carcinomas, whereas type C is an
advanced stage of types A and B. If Noguchi type A and B
peripheral tumors are truly in situ, noninvasive carcinomas,
limited resection would be the management of choice for
these tumors. As a result, in August 1998 we started this
prospective clinical trial with intraoperative frozen-section
examination to establish the Noguchi classification and lim-
ited resection for probable in situ adenocarcinoma with
GGO characteristics in the lung periphery.
As noted, Shimosato and associates6 evaluated cancer
fibrotic focus or scarring and patient prognosis. Increased
lymph node metastasis and pleural and blood vessel inva-
sion were present with greater scarring and fibrotic focus.
Aoki and colleagues15 noted the pleural indentation and
vascular convergence increased with tumor development in
Noguchi type B and C tumors. This information was incor-
porated into our patient selection criteria.
A concern in our trial was the accuracy of frozen-
section examination. The correct classification as atypical
adenomatous hyperplasias or Noguchi type A,16 or as
Noguchi type B or type C tumors,has been reported as
being difficult, even more so with frozen sections. We
think that the equipment developed for this trial and the
methods and techniques applied contributed significantly
to our outcomes. Finding the GGO “spongelike” structure
could be felt in the lung made locating the lesion and
ensuring sufficient resection margin much easier. The
customized stapling cartridge and negative-pressure
specimen inflation were useful in frozen-section prepa-
ration. They made it much easier to work with the spec-
imen. Stereoscopic microscopy enabled the pathologist to
locate regions of interest for detailed examination. For
Noguchi subtype determination, VvG staining proved to
be a powerful aid in separating Noguchi type A and B
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gether with the expertise of our pathologist, resulted in
high frozen-section examination accuracy: only 1 type B
lesion in 50 cases was recategorized as type C postoper-
atively. This patient underwent only a wedge resection
and, after being fully informed of the underdiagnosis,
potential outcomes, and additional treatment options, de-
cided not to undergo any further treatment. He is still
alive after more than 5 years without recurrence.
The other patients with 14 Noguchi type C tumor,
whose diagnoses were confirmed by postoperative patho-
logic study, underwent lobectomy and systematic lymph
node dissection after the frozen-section diagnosis. De-
tailed pathologic study after the operation revealed no
nodal involvement, pulmonary metastases, lymphatic
permeation, or vascular invasion in the specimens. It is
likely that these patients will survive. Kondo and col-
leagues17 studied air-containing lesions 2 cm or smaller,
including GGO or subsolid tumors. These lesions were of
interest if their opacity area decreased by more than 50%
on the mediastinum-setting CT from the lung-setting CT.
They reported that this patient cohort survived 5 years
without recurrences after either standard or limited re-
section, and most of them had no node metastases or
vessel involvement. So although Noguchi type C tumors
are invasive, they may well represent an early invasive
stage. On the basis of our finding of no nodal involve-
ment, lymphatic permeation, or vascular invasion, and
Kondo and colleagues’ similar results and survival
rates,17 we conjecture that Noguchi type C tumors in our
trial might well also have been curatively treated by
limited resection. However, we did not address this issue
in our trial.
During the trial, Noguchi classification assessment took
about an hour. This was mostly because we extensively
recorded sample images for study purposes. Our pathologist
believes that in routine practice, without extensive image
recording, the determination can be accomplished in 15 to
20 minutes.
There was no definite difference in size distribution
among subtypes. However, all Noguchi type C tumors were
1 cm or larger, whereas other subtypes included subcenti-
meter tumors. This strengthens the suggestion that limited
resection is indicated when a GGO tumor is smaller than 1
cm. Although this contradicts our previous review5 and a
recent report on subcentimeter lung cancers by the Mayo
Clinic,13 that is probably because those series included
non-GGO lesions.
In conclusion, Noguchi classification type A and B
tumors appear to be in situ, noninvasive carcinomas, and
limited resection achieves the goals of local control and
survival. With about 5.5 years total on this study, it may
be still too early for strong conclusions. Considering the
The Journal of Thoraciprobable slow-growing nature of GGO lesions,18 5 years
of follow-up is not long enough to conclude that the
disease is cured. We will probably have to continue our
follow-up for an additional 5 years. However, initial
results are encouraging. With the customized stapling
cartridges, negative-pressure specimen preparation and
inflation, stereoscopic microscopy, VvG staining, and a
skilled pathologist, frozen-section classification of Nogu-
chi subtype has been highly accurate. Our results suggest
that lung tumors 2 cm or less in diameter with high-
resolution CT scan findings of GGO and without evident
pleural indentations or vascular convergence may be safely
managed with only limited resection.
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